Adult ovarian granulosa cell tumor transcriptomics: prevalence of FOXL2 target genes misregulation gives insights into the pathogenic mechanism of the p.Cys134Trp somatic mutation

Ovarian granulosa cell tumors (OGCT) are the most frequent kind of sex cord-stromal tumors, and represent ∼2–5% of all ovarian malignancies. OGCTs exist as two entities, juvenile and adult types, with specific clinical and pathological characteristics. The molecular pathogenesis of these tumors has just begun to be unraveled. Indeed, recent studies have indicated that mutation and/or misregulation of the key ovarian transcription factor FOXL2 has a role in OGCT formation, although the mechanisms remain unclear. To better understand the molecular characteristics of OGCT, we studied the transcriptomic profiles of ten human adult-type OGCT samples, as well as ethnically matched granulosa cell (GC) controls. We find that the OGCT samples analyzed herein exhibit several hallmarks of cancer, including increased expression of genes linked to cell proliferation, but decreased expression of those conferring sensitivity to cell death. Moreover, genes differentially expressed in OGCTs are significantly enriched for known FOXL2 target genes, consistently with the prevalence of FOXL2 somatic mutation in these tumors. Expression of these targets is altered in a way expected to promote malignant transformation, for instance, through induction of genes associated with faster cell cycling and downregulation of genes associated with cell death. Over time, such defects may be responsible at least partly for the malignant transformation of healthy GCs into OGCT. These insights into the molecular pathogenesis of OGCTs may open the way to new efforts in the development of more targeted therapeutic strategies for OGCT patients.

[1]  C. Lorson,et al.  Transcription factor FOXL 2 protects granulosa cells from stress and delays cell cycle : role of its regulation by the SIRT 1 deacetylase , 2011 .

[2]  C. Glass,et al.  Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. , 2010, Molecular cell.

[3]  B. Benayoun,et al.  Functional Exploration of the Adult Ovarian Granulosa Cell Tumor-Associated Somatic FOXL2 Mutation p.Cys134Trp (c.402C>G) , 2010, PloS one.

[4]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Kangseok Lee,et al.  Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W) , 2011, Oncogene.

[6]  J. Klefström,et al.  GATA4 protects granulosa cell tumors from TRAIL-induced apoptosis. , 2010, Endocrine-related cancer.

[7]  Brad T. Sherman,et al.  DAVID: Database for Annotation, Visualization, and Integrated Discovery , 2003, Genome Biology.

[8]  Hyoung-Pyo Kim,et al.  Transcriptional Activation of the Human Manganese Superoxide Dismutase Gene Mediated by Tetradecanoylphorbol Acetate* , 1999, The Journal of Biological Chemistry.

[9]  D. Schlessinger,et al.  The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome , 2001, Nature Genetics.

[10]  N. Yoo,et al.  Mutational analysis of FOXL2 codon 134 in granulosa cell tumour of ovary and other human cancers , 2010, The Journal of pathology.

[11]  W. Holzgreve,et al.  Characterization of an immortalized human granulosa cell line (COV434). , 2000, Molecular human reproduction.

[12]  D. Huntsman,et al.  The Specificity of the FOXL2 c.402C>G Somatic Mutation: A Survey of Solid Tumors , 2009, PloS one.

[13]  B. Benayoun,et al.  Transcription factor FOXL2 protects granulosa cells from stress and delays cell cycle: role of its regulation by the SIRT1 deacetylase. , 2011, Human molecular genetics.

[14]  M. Pisarska,et al.  Transcriptional factor FOXL2 interacts with DP103 and induces apoptosis. , 2005, Biochemical and biophysical research communications.

[15]  R. Butzow,et al.  The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary , 2010, Modern Pathology.

[16]  E. Simpson,et al.  Aromatase Is a Direct Target of FOXL2: C134W in Granulosa Cell Tumors via a Single Highly Conserved Binding Site in the Ovarian Specific Promoter , 2010, PloS one.

[17]  R. Veitia,et al.  Evolution and expression of FOXL2 , 2002, Journal of medical genetics.

[18]  Israel Steinfeld,et al.  BMC Bioinformatics BioMed Central , 2008 .

[19]  M. Matzuk,et al.  Defective gonadotropin-dependent ovarian folliculogenesis and granulosa cell gene expression in inhibin-deficient mice. , 2010, Endocrinology.

[20]  Chunyu Liu,et al.  Removing Batch Effects in Analysis of Expression Microarray Data: An Evaluation of Six Batch Adjustment Methods , 2011, PloS one.

[21]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[22]  B. Benayoun,et al.  The forkhead factor FOXL2: a novel tumor suppressor? , 2010, Biochimica et biophysica acta.

[23]  Alok J. Saldanha,et al.  Java Treeview - extensible visualization of microarray data , 2004, Bioinform..

[24]  Ryan D. Morin,et al.  Mutation of FOXL2 in granulosa-cell tumors of the ovary. , 2009, The New England journal of medicine.

[25]  W. Fischer,et al.  FoxL2 and Smad3 Coordinately Regulate Follistatin Gene Transcription* , 2009, Journal of Biological Chemistry.

[26]  Hidetoshi Shimodaira,et al.  Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..

[27]  B. Benayoun,et al.  The new molecular biology of granulosa cell tumors of the ovary , 2009, Genome Medicine.

[28]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[29]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[30]  R. Veitia,et al.  Differential aggregation and functional impairment induced by polyalanine expansions in FOXL2, a transcription factor involved in cranio-facial and ovarian development. , 2007, Human molecular genetics.

[31]  B. Benayoun,et al.  Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations. , 2009, Human molecular genetics.

[32]  N. East,et al.  Granulosa cell tumour: a recurrence 40 years after initial diagnosis. , 2005, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[33]  M. Fellous,et al.  Extinction of FOXL2 expression in aggressive ovarian granulosa cell tumors in children. , 2007, Fertility and sterility.

[34]  J. Dausset,et al.  Potential targets of FOXL2, a transcription factor involved in craniofacial and follicular development, identified by transcriptomics , 2007, Proceedings of the National Academy of Sciences.

[35]  A. Psyrri,et al.  Granulosa cell tumor of the ovary. , 2008, Cancer treatment reviews.

[36]  M. Sheikh,et al.  Post-transcriptional regulation of the DNA damage-inducible gadd45 gene in human breast carcinoma cells exposed to a novel retinoid CD437. , 1999, Nucleic acids research.

[37]  Martin M. Matzuk,et al.  Conditional Deletion of Smad1 and Smad5 in Somatic Cells of Male and Female Gonads Leads to Metastatic Tumor Development in Mice , 2007, Molecular and Cellular Biology.

[38]  R. Lovell-Badge,et al.  Somatic Sex Reprogramming of Adult Ovaries to Testes by FOXL2 Ablation , 2009, Cell.

[39]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[40]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.